Price $73.19 |
Market Cap
213.29B
|
Sector Health Care |
Div. Growth
2.10%
|
|
P/E
35.7
|
P/B
8.15
|
P/S
5.14
|
Dividend %
2.60%
|
|
P/CF
118.0
|
P/FCF
70.6
|
Op. Cash Flow
10.92M
|
FCF
1.1
|
|
Op. Margin
19.60%
|
Net Margin
14.70%
|
ROE
19.90%
|
ROI
11.20%
|
|
ROA
7.30%
|
EPS Growth
168.70%
|
Current Ratio
1.2
|
Debt/Equity
74.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bausch Health Companies Inc (BHC) | $23.13 | - | - | 8.6B | Strong Buy |
| Champions Oncology Inc (CSBR) | $7.90 | - | - | 114.3M | Strong Buy |
| VIVUS, Inc. (VVUS) | $3.65 | - | - | 44.6M | Strong Buy |
| Cryolife Inc (CRY) | $27.55 | - | - | 1.05B | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $5.82 | - | - | 88.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
